A Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of the Head and Neck

Trial Profile

A Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of the Head and Neck

Completed
Phase of Trial: Phase 0

Latest Information Update: 22 Jun 2015

At a glance

  • Drugs Cisplatin (Primary) ; Raltegravir (Primary) ; Docetaxel
  • Indications Head and neck cancer
  • Focus Pharmacodynamics; Pharmacogenomic
  • Most Recent Events

    • 17 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 13 Aug 2013 Planned end date changed from 1 May 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 19 Feb 2013 Planned end date changed from 1 Dec 2013 to 1 May 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top